.Merck trumps earnings assumptions, brings up purchases overview on sturdy need for top medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Estimates as Keytruda Sales Increase BloombergMerck Supply: Pharma Titan Posts Sturdy End Results, But Overview Tumbles Short Financier's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats revenue and also sales requirements in the middle of Keytruda strong point, yet offers blended full-year overview MarketWatch.